JPMorgan Adjusts XPENG-W Price Target to HK$118, Keeps Overweight Rating

Stock News
06/01

JPMorgan has updated its research report on XPENG-W (HKEX: 09868), revising its 2026 loss forecast to RMB 3.92 billion from a previous estimate of RMB 3.891 billion. The adjusted loss projection is set at RMB 3.47 billion, reflecting the company's first-quarter performance. Consequently, the bank has lowered its target price from HK$135 to HK$118.

The report notes that XPENG's Q1 results were largely in line with expectations. JPMorgan maintains a positive outlook on the company, anticipating an acceleration in sales growth starting from the second quarter. Additionally, expansion in overseas markets and developments related to artificial intelligence are expected to support a long-term potential revaluation of the stock. The firm reaffirms its "Overweight" rating.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10